Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MHLW Extends GSK’s Relenza Expiration Date

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare extended expiration dates for its stockpile of flu drug Relenza (zanamivir) from its current five to seven years. The decision was based on clinical data provided by Relenza maker GlaxoSmithKline showing no change in the drug's efficacy and safety in seven years. The Ministry took a similar measure and extended expiration dates for another flu drug Tamiflu (oseltamivir) to seven years last November. Since 2006, Japanese central and local governments have stockpiled enough Relenza to treat 4.68 million people. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts